Search
Patexia Research
Case number IPR2016-00408

Boehringer Ingelheim GmbH et al. v. AbbVie Biotechnology Ltd. > Documents

Date Field Doc. No.PartyDescription
Oct 19, 2017 49 Decision - re Patent Owner's Motion to Preserve Record Download
Jul 31, 2017 48 Patent Owner's Notice of Appeal Download
Jul 28, 2017 47 Patent Owner's Motion For Preservation Of The Record Pending Appeal And Motion To Expunge Confidential Information Under 37 C.F.R. 42.56 Download
Jul 6, 2017 46 Final Written Decision Download
May 12, 2017 45 Record of Oral Hearing Download
Mar 30, 2017 44 Petitioner's Demonstrative Exhibits Download
Mar 30, 2017 43 AbbVie's Demonstrative Exhibits Download
Mar 24, 2017 42 Hearing Order Download
Mar 10, 2017 40 Patent Owner's Request for Oral Argument Download
Mar 10, 2017 41 Petitioner's Request for Oral Argument Download
Feb 24, 2017 39 Patent Owner's Objections to Evidence Download
Feb 16, 2017 38 Petitioner's Reply to Patent Owner's Response Download
Feb 16, 2017 37 Petitioner's Updated Exhibit List Download
Feb 16, 2017 1056 Rau 1999, Rheumatol., Vol. 58 (Suppl. 1) 1/41. P2 (1999) Download
Feb 16, 2017 1032 CV of Michael H. Weisman, M.D. Download
Feb 16, 2017 1035 Harvey Dep. Tr. Download
Feb 16, 2017 1042 Allan Gibofsky 2013 Payments Download
Feb 16, 2017 1047 Allan Gibofsky 2015 Report Download
Feb 16, 2017 1034 Hausman Dep. Tr. Download
Feb 16, 2017 1033 CV of Dr. William J. Jusko, Ph.D. Download
Feb 16, 2017 1050 Vinks ¿¿¿ Chapter 3 from Pediatric Psychopharmacology Download
Feb 16, 2017 1045 Allan Gibofsky 2013 Report Download
Feb 16, 2017 1051 Vinks Marked-up Version of Excerpts from Clinical Pharmacokinetics Concepts and Applications Download
Feb 16, 2017 1038 Vinks Dep. Tr. Download
Feb 16, 2017 1043 Allan Gibofsky 2014 Payments Download
Feb 16, 2017 1044 Allan Gibofsky 2015 Payments Download
Feb 16, 2017 1052 BASF, The Pharma Letter from June 23, 2000 Download
Feb 16, 2017 1048 USPTO Letter re Patent Term Extension Certificate Download
Feb 16, 2017 1036 Sailstad Dep. Tr. Download
Feb 16, 2017 1046 Allan Gibofsky 2014 Report Download
Feb 16, 2017 1037 Gibofsky Dep. Tr. Download
Feb 16, 2017 1054 Cambridge Antibody Technology Group Press Release from November 9, 1998 Download
Feb 16, 2017 1055 REMICADE Label (December 2000) Download
Feb 16, 2017 1049 Vinks Dep. Tr. From IPR2016-00172 Download
Feb 16, 2017 1041 Gibofsky Webpage Download
Feb 10, 2017 36 Patent Owner's Third Updated Mandatory Notices Download
Jan 23, 2017 35 Notice of Joint Stipulation to Modify Due Dates 2, 4 and 5 Download
Jan 3, 2017 34 Petitioner's Updated Mandatory Notices Download
Dec 19, 2016 32 Petitioner's Notice of Deposition of Dr. Jerry A. Hausman Download
Dec 19, 2016 33 Petitioner's Notice of Deposition of Jeffrey M. Sailstad Download
Dec 19, 2016 29 Petitioner's Notice of Deposition of Dr. Allan Gibofsky Download
Dec 19, 2016 31 Petitioner's Notice of Deposition of Dr. Brian E. Harvey Download
Dec 19, 2016 30 Petitioner's Notice of Deposition of Dr. Alexander A. Vinks Download
Dec 16, 2016 28 Notices of Joint Stipulation to Modify Due Dates 2 and 4 Download
Nov 4, 2016 27 Petitioner's Objections to Patent Owner's Exhibits Download
Oct 28, 2016 2171 CVS-caremarkTM Performance Drug List (Oct. 2015) Download
Oct 28, 2016 2167 Rigby, ARTHRITIS & RHEUM. (2012) Download
Oct 28, 2016 2168 Tak, ARTHRITIS & RHEUM. (2012) Download
Oct 28, 2016 2151 Mayo Clinic Staff, Rheumatoid arthritis Download
Oct 28, 2016 2197 Louder, AM. HEALTH DRUG BENEFITS (2016) Download
Oct 28, 2016 24 Patent Owner's Response Download
Oct 28, 2016 2214 ClinicalTrials.gov identifier NCT02720120 Download
Oct 28, 2016 2142 O'Dell (2002) Download
Oct 28, 2016 2184 Approval Letter for 99-0128 (Nov. 10, 1999) Download
Oct 28, 2016 2136 Hamilton, CONTROLLED CLIN. TRIALS (2000) Download
Oct 28, 2016 2134 Approval Letter, Adalimumab (HUMIRA) (Dec. 31, 2002) Download
Oct 28, 2016 2188 SEC Form 10-K for Abbott Laboratories (FY ended Dec. 31, 2003) Download
Oct 28, 2016 2210 D¿¿rner, ARTHRITIS RESEARCH THERAPY (2006) Download
Oct 28, 2016 2148 Hasler, (1996) Download
Oct 28, 2016 2160 ClinicalTrials.gov identifier NCT00785928 Download
Oct 28, 2016 2200 Curtis, & Singh, CLIN. THER. (2011) Download
Oct 28, 2016 2195 Approval Letter for BL 103795/5110 (Oct. 17, 2003) Download
Oct 28, 2016 2138 Statement of Janet Woodcock (May 2, 2007) Download
Oct 28, 2016 2209 Philippidis, Top 10 Clinical Trial Failures of 2014 (Feb. 9, 2015) Download
Oct 28, 2016 2194 U.S. FDA, How Drugs are Developed and Approved Download
Oct 28, 2016 2215 UCB Pharma Press Release (Jul. 28, 2015) Download
Oct 28, 2016 2165 Philippidis, Top 10 Clinical Trial Failures of 2013 (Feb. 3, 2014) Download
Oct 28, 2016 2191 GlobalData, Top 50 pharmaceutical products by global sales Download
Oct 28, 2016 2213 ClinicalTrials.gov identifier NCT00673920 Download
Oct 28, 2016 2137 Eckardt & Casadevall, NEPHROL. DIAL. TRANSPLANT. (2003) Download
Oct 28, 2016 2199 Greenapple, AM. HEALTH DRUG BENEFITS (2012) Download
Oct 28, 2016 2169 Torgerson, CONTROL. CLIN. TRIALS (2001) Download
Oct 28, 2016 2143 Ruderman & Tambar, Rheumatoid Arthritis Download
Oct 28, 2016 2149 Ruffing & Bingham, Rheumatoid Arthritis Signs and Symptoms Download
Oct 28, 2016 2177 Summary Review of sBLA 125057/110 (Jan. 16, 2008) Download
Oct 28, 2016 2152 ClinicalTrials.gov identifier NCT00090129 Download
Oct 28, 2016 2154 Rankin, BR. J. RHEUMATOL. (1995) Download
Oct 28, 2016 2181 Supplemental Approval Letter for BLA 125057/232 (Sept. 28, 2012) Download
Oct 28, 2016 2211 Emery, PLOS ONE (2014) Download
Oct 28, 2016 2161 ClinicalTrials.gov identifier NCT01198002 Download
Oct 28, 2016 2189 SEC Form 10-K for Abbott Laboratories (FY ended Dec. 31, 2005) Download
Oct 28, 2016 2163 ClinicalTrials.gov identifier NCT01262365 Download
Oct 28, 2016 2155 Tishler, ANN. RHEUM. DIS. (1992) Download
Oct 28, 2016 2190 Anantharaman, FROST & SULLIVAN (July 20, 2004) Download
Oct 28, 2016 2208 Philippidis, Top 10 Clinical Trial Failures of 2012 (Feb. 5, 2013) Download
Oct 28, 2016 2193 Berndt (1997) Download
Oct 28, 2016 2180 Approval Letter for sBLA 125057/114 (Feb. 21, 2008) Download
Oct 28, 2016 2203 Sylwestrzak, AM. HEALTH DRUG BENEFITS (2014) Download
Oct 28, 2016 2206 Abbott Labs., Helping Your RA Patients Live More Normal Lives Download
Oct 28, 2016 2166 Rayes & Touma, DRUG DESIGN, DEVELOPMENT AND THERAPY (2014) Download
Oct 28, 2016 2173 UnitedHealthcare 2015 Four-Tier Prescription Drug List (Jul. 2015) Download
Oct 28, 2016 2218 Standing Protective Order Download
Oct 28, 2016 2135 Adalimumab (HUMIRA)Package Insert (Dec. 2002) Download
Oct 28, 2016 2219 Boehringer Ingelheim Press Release (Oct. 26, 2016) Download
Oct 28, 2016 2174 Exhibit M to Williams Declaration (Feb. 7, 2014) Download
Oct 28, 2016 2205 Abbott, Introducing More Reasons Than Ever To Choose Humira Download
Oct 28, 2016 2164 Papp, CURRENT MED. RES. & OP. (2010) Download
Oct 28, 2016 2216 Wallace, ARTHRITIS CARE & RES. (2016) Download
Oct 28, 2016 2140 Khan (2002) Download
Oct 28, 2016 2176 Approval Letter for BL 125057/45 (Oct. 3, 2005) Download
Oct 28, 2016 2182 Supplemental Approval Letter for BLA 125057/S-363 (Sept. 9, 2015) Download
Oct 28, 2016 2178 Approval Letter for BL 12057/89 (Feb. 27, 2007) Download
Oct 28, 2016 2150 Bingham & Ruffing, Rheumatoid Arthritis Treatment Download
Oct 28, 2016 2146 Gibofsky, AM. J. MEDICINE (1997) Download
Oct 28, 2016 2183 Supplemental Approval Letter for BLA 125057/S-397 (June 30, 2016) Download
Oct 28, 2016 2186 Golimumab/SIMPONI label (Apr. 2009) Download
Oct 28, 2016 2185 Certolizumab pegol/CIMZIA label (Nov. 18, 2009) Download
Oct 28, 2016 2144 Furst, Arthritis & Rheumatism (1996) Download
Oct 28, 2016 2202 Navarro-Mill¿¿n, PLOS ONE (2016) Download
Oct 28, 2016 2147 Curriculum Vitae of Dr. Allan Gibofsky Download
Oct 28, 2016 2204 Huynh, PATIENT PREFERENCES AND ADHERENCE (2014) Download
Oct 28, 2016 25 Patent Owner's Motion to Seal Under 37 C.F.R. Sec. 42.54 Download
Oct 28, 2016 2196 Chilton & Collett, MUSCULOSKELET. CARE (2008) Download
Oct 28, 2016 2141 ClinicalTrials.gov identifier NCT00077870 Download
Oct 28, 2016 2192 Palmer, Top 10 rheumatoid arthritis drugs 2013 Download
Oct 28, 2016 2187 SEC Form 10-K for AbbVie Inc. (FY ended Dec. 31, 2015) Download
Oct 28, 2016 2201 Williams & Edwards, RHEUMATOLOGY (2006) Download
Oct 28, 2016 2145 Furst, ANN. RHEUM. DIS. (2008) Download
Oct 28, 2016 2158 Rau et al. (2000) (Original German) (High-resolution) Download
Oct 28, 2016 2156 ClinicalTrials.gov identifier NCT00406419 Download
Oct 28, 2016 2162 ClinicalTrials.gov identifier NCT01261793 Download
Oct 28, 2016 2175 Curriculum Vitae of Dr. Jerry A. Hausman Download
Oct 28, 2016 2207 Supplemental Approval Letter for BLA 125057/356 (Sept. 23, 2014) Download
Oct 28, 2016 2170 Wallace, ANN. RHEUM. DIS. (2014) Download
Oct 28, 2016 2153 Rheumatoid Arthritis: What is Rheumatoid Arthritis? Download
Oct 28, 2016 2157 ClinicalTrials.gov identifier NCT00476996 Download
Oct 28, 2016 2172 2015 Express Scripts Basic Formulary (Aug. 2014) Download
Oct 28, 2016 2198 Lisicki & Chu, POSTGRADUATE MEDICINE (2008) Download
Oct 28, 2016 2179 Approval Letter for BL 125057/110 (Jan, 18, 2008) Download
Oct 28, 2016 2133 Genovese, ARTHRITIS & RHEUM. (2008) Download
Oct 28, 2016 26 Patent Owner's Updated Exhibit List Download
Oct 28, 2016 2212 ClinicalTrials.gov identifier NCT00485589 Download
Oct 28, 2016 2139 Sander & Rau, INT¿¿¿L J. CLIN. PHARM. THERAPEUTICS (1998) Download
Oct 28, 2016 2159 ClinicalTrials.gov identifier NCT00624351 Download
Oct 28, 2016 2060 Weisman (1997) Download
Oct 28, 2016 2096 MwPharm ver. 3.82 (update of ver. 3.60) (Feb. 16, 2014) Download
Oct 28, 2016 2065 Smolen (2000) Download
Oct 28, 2016 2104 Findlay, J. PHARM. BIOMED. ANAL. (2000) Download
Oct 28, 2016 2093 Weaver, CURRENT MED. RES. & OP. (2006) Download
Oct 28, 2016 2047 Jusko (Feb. 22, 2013) Download
Oct 28, 2016 2091 Rowland & Tozer (1995) Download
Oct 28, 2016 2111 Kress (Dec. 24, 2002) Download
Oct 28, 2016 2109 Mire-Sluis, J. IMMUNOLOGICAL METHODS (2004) Download
Oct 28, 2016 2112 Proudfoot (2002) Download
Oct 28, 2016 2061 Furst (2003) Download
Oct 28, 2016 2048 Mager & Jusko (2002) Download
Oct 28, 2016 2081 WO98/004281 Download
Oct 28, 2016 2051 DeVane & Jusko (1982) Download
Oct 28, 2016 2113 Taylor, ARTHRITIS & RHEUMATISM (2000) Download
Oct 28, 2016 2130 Guidance for Industry (Feb. 1999) Download
Oct 28, 2016 2056 Notice of Deposition of Michael Weisman Download
Oct 28, 2016 2052 Lon (2013) Download
Oct 28, 2016 2117 Smolen, ANN. RHEUM. DIS. (2013) Download
Oct 28, 2016 2129 Clowse, 2015 ACR/ARHP ANNUAL MEETING (2015) Download
Oct 28, 2016 2100 The Lenercept MS Study Group, NEUROLOGY (1999) Download
Oct 28, 2016 2062 Paulus (2000) Download
Oct 28, 2016 2053 US 2007/0275063 A1 Download
Oct 28, 2016 2116 Stephens, IMMUNOLOGY (1995) Download
Oct 28, 2016 2124 Casadevall, NEPHROL. DIAL. TRANSPLANT. (2003) Download
Oct 28, 2016 2073 Declaration of Dr. Jerry A. Hausman (REDACTED VERSION) Download
Oct 28, 2016 2125 Rossert, J. AM. SOC. NEPHROL. (2004) Download
Oct 28, 2016 2084 Mevorach & Paget (2000) Download
Oct 28, 2016 2088 Moreland, ARTHRITIS & RHEUMATISM (1997) Download
Oct 28, 2016 2071 Declaration of Dr. Allan Gibofsky Download
Oct 28, 2016 2097 Neef & Vinks, PHARMACEUTISCH WEEKBLAD (2000) (Dutch Original) Download
Oct 28, 2016 2101 Feldmann & Maini, ANNU. REV. IMMUNOL. (2001) Download
Oct 28, 2016 2107 Miller, PHARMACEUTICAL RESEARCH (2001) Download
Oct 28, 2016 2110 Curriculum Vitae of Jeff Sailstad Download
Oct 28, 2016 2095 MW\PHARM Ver. 3.15, Vols. 1-3 Download
Oct 28, 2016 2057 Barnett (1998) Download
Oct 28, 2016 2055 Furst et al. (May 2003) Download
Oct 28, 2016 2122 Ross, ANN. NEUROL. (2000) Download
Oct 28, 2016 2049 Cao (2013) Download
Oct 28, 2016 2085 Gibofsky, CURRENT MED. RES. & OP.(2006) Download
Oct 28, 2016 2079 Mordenti, TOXICOLOGIC PATHOLOGY (1999) Download
Oct 28, 2016 2083 Weinblatt, TRANSACTIONS OF THE AM. CLIN. & CLIMATOLOGICAL ASS'n (2013) Download
Oct 28, 2016 2068 Furst (2013) Download
Oct 28, 2016 2118 Curriculum Vitae of Dr. Alexander A. Vinks Download
Oct 28, 2016 2127 Curriculum Vitae of Dr. Brian E. Harvey Download
Oct 28, 2016 2050 Woo & Jusko (2007) Download
Oct 28, 2016 2105 Kavanaugh, RHEUMATIC DISEASE CLINICS OF N. AM. (1998) Download
Oct 28, 2016 2067 Furst (May 2002) Download
Oct 28, 2016 2064 Wolfe (2001) Download
Oct 28, 2016 2058 Maini (1999) Download
Oct 28, 2016 2075 Declaration of Dr. Alexander A. Vinks Download
Oct 28, 2016 2069 Transcript of Deposition of William Jusko (Sep. 30, 2016) Download
Oct 28, 2016 2099 Etanercept-ENBREL¿¿ label (1998) Download
Oct 28, 2016 2098 Neef & Vinks, PHARMACEUTICS WEEKLY (2000) (English Translation) Download
Oct 28, 2016 2128 Nestorov, J. RHEUMATOL. (2005) Download
Oct 28, 2016 2094 Rowland & Tozer (2011) Download
Oct 28, 2016 2046 Notices of Deposition of William Jusko Download
Oct 28, 2016 2059 Ianculescu & Weisman (2016) Download
Oct 28, 2016 2087 Sedger & McDermott, CYTOKINE & GROWTH FACTOR REVIEWS (2014) Download
Oct 28, 2016 2077 Karlsson, BR. J. CLIN. PHARMACOL. (1998) Download
Oct 28, 2016 2106 Points to Consider (Feb. 28, 1997) Download
Oct 28, 2016 2066 Furst (May 2000) Download
Oct 28, 2016 2119 van de Putte et al. (2004) Download
Oct 28, 2016 2054 Amendment and Petition for Extension of Time Download
Oct 28, 2016 2115 Sailstad, THE AAPS JOURNAL (2014) Download
Oct 28, 2016 2132 Genovese, ANN RHEUM DIS (2013) Download
Oct 28, 2016 2074 Declaration of Jeffrey M. Sailstad Download
Oct 28, 2016 2123 Christen, HUMAN IMMUNOLOGY (1999) Download
Oct 28, 2016 2076 van de Putte 2000 (Blowup of Ex. 1009) Download
Oct 28, 2016 2126 Smolen, ANN. RHEUM. DIS. (2015) Download
Oct 28, 2016 2072 Declaration of Dr. Brian Harvey Download
Oct 28, 2016 2080 Sacks, JAMA (2014) Download
Oct 28, 2016 2092 Prevoo, ARTHRITIS & RHEUMATISM (1995) Download
Oct 28, 2016 2070 Transcript of Deposition of Michael Weisman (Oct. 10, 2016) Download
Oct 28, 2016 2131 DiMasi, J. HEALTH ECON. (2003) Download
Oct 28, 2016 2114 Maini & Feldmann, ARTHRITIS RES. (2002) Download
Oct 28, 2016 2063 Smolen (2007) Download
Oct 28, 2016 2108 Clark, IMMUNOLOGY TODAY (2000) Download
Oct 28, 2016 2120 O¿¿¿Dell, ANN. RHEUM. DIS. (1996) Download
Sep 21, 2016 23 Notice of Deposition of Michael Weisman, M.D. Download
Sep 21, 2016 22 Patent Owner's Second Updated Mandatory Notices Download
Sep 21, 2016 21 Patent Owner's Power of Attorney Download
Sep 19, 2016 20 ORDER Patent Owner's Motions for Pro Hac Vice Admission Download
Sep 16, 2016 18 Notice of Deposition of William J. Jusko, Ph.D. Download
Sep 16, 2016 19 Notice of Joint Stipulation to Modify Due Date 1 Download
Sep 15, 2016 17 Petitioner's Updated Mandatory Notices Download
Aug 15, 2016 16 Notice of Joint Stipulation to Modify Due Dates 1 and 2 Download
Jul 25, 2016 13 Patent Owner's Motion for Admission Pro Hac Vice of William G. McElwain Download
Jul 25, 2016 2045 Declaration of Amy K. Wigmore Download
Jul 25, 2016 14 Patent Owner's Motion for Admission Pro Hac Vice of Amy K. Wigmore Download
Jul 25, 2016 2044 Declaration of William G. McElwain Download
Jul 25, 2016 15 Patent Owner's Updated Exhibit List Download
Jul 21, 2016 11 Patent Owner's Objections To Evidence Download
Jul 21, 2016 12 Petitioner's Objections to Patent Owner's Exhibits Download
Jul 7, 2016 9 board Decision to Institute Inter Partes Review Download
Jul 7, 2016 10 board Scheduling Order Download
Jun 30, 2016 8 patent_owner Patent Owner's Updated Mandatory Notices Download
Apr 8, 2016 7 patent_owner Patent Owner's Preliminary Response Download
Apr 8, 2016 2007 patent_owner Exhibit 2007 - Rituximab/RITUXIN label Download
Apr 8, 2016 2019 patent_owner Exhibit 2019 - Rau 1999 (original German) Download
Apr 8, 2016 2043 patent_owner Exhibit 2043 - RESERVED Download
Apr 8, 2016 2039 patent_owner Exhibit 2039 - RESERVED Download
Apr 8, 2016 2029 patent_owner Exhibit 2029 - Infliximab/REMICADE label Download
Apr 8, 2016 2011 patent_owner Exhibit 2011 - Basiliximab/SIMULECT label Download
Apr 8, 2016 2042 patent_owner Exhibit 2042 - RESERVED Download
Apr 8, 2016 2002 patent_owner Exhibit 2002 - Declaration of Michael E. Weinblatt Download
Apr 8, 2016 2008 patent_owner Exhibit 2008 - Trastuzumab/HERCEPTIN label Download
Apr 8, 2016 2028 patent_owner Exhibit 2028 - Bross, et al. (Jun. 2001) Download
Apr 8, 2016 2012 patent_owner Exhibit 2012 - Palivizumab/SYNAGIS label Download
Apr 8, 2016 2034 patent_owner Exhibit 2034 - Moreland, et al. (2000) Download
Apr 8, 2016 2040 patent_owner Exhibit 2040 - RESERVED Download
Apr 8, 2016 2017 patent_owner Exhibit 2017 - Rowland and Tozer (3d ed. 1995) Download
Apr 8, 2016 2001 patent_owner Exhibit 2001 - Declaration of Janet Pope Download
Apr 8, 2016 2032 patent_owner Exhibit 2032 - RESERVED Download
Apr 8, 2016 2037 patent_owner Exhibit 2037 - Jusko (1980) Download
Apr 8, 2016 2038 patent_owner Exhibit 2038 - Furst, et al. (May 2003) Download
Apr 8, 2016 2013 patent_owner Exhibit 2013 - Gemtuzumab/MYLOTARG label Download
Apr 8, 2016 2003 patent_owner Exhibit 2003 - Declaration of Diane R. Mould Download
Apr 8, 2016 2026 patent_owner Exhibit 2026 - Mason, et al. (2002) Download
Apr 8, 2016 2016 patent_owner Exhibit 2016 - RESERVED Download
Apr 8, 2016 2004 patent_owner Exhibit 2004 - Declaration of Mr. Medgar Williams Download
Apr 8, 2016 2006 patent_owner Exhibit 2006 - Kupper II Declaration Download
Apr 8, 2016 2010 patent_owner Exhibit 2010 - Daclizumab/ZENAPAX label Download
Apr 8, 2016 2021 patent_owner Exhibit 2021 - RESERVED Download
Apr 8, 2016 2018 patent_owner Exhibit 2018 - Porter and Charman (2000) Download
Apr 8, 2016 2025 patent_owner Exhibit 2025 - Wolfe, et al. (2001) Download
Apr 8, 2016 2036 patent_owner Exhibit 2036 - Radwanski, et al. (1998) Download
Apr 8, 2016 2020 patent_owner Exhibit 2020 - Rau 1999 (certified English translation) Download
Apr 8, 2016 2030 patent_owner Exhibit 2030 - Furst, et al. (Apr. 2001) Download
Apr 8, 2016 2024 patent_owner Exhibit 2024 - Maini, et al. (1998) Download
Apr 8, 2016 2009 patent_owner Exhibit 2009 - Abciximab/REOPRO label Download
Apr 8, 2016 2035 patent_owner Exhibit 2035 - Kavanaugh, et al. (2003) Download
Apr 8, 2016 2031 patent_owner Exhibit 2031 - Timmerman (Apr. 16, 2012) Download
Apr 8, 2016 2022 patent_owner Exhibit 2022 - Vincent, et al. (2013) Download
Apr 8, 2016 2005 patent_owner Exhibit 2005 - Kupper I Declaration Download
Apr 8, 2016 2015 patent_owner Exhibit 2015 - Adalimumab M10-261 Clinical Study Report Download
Apr 8, 2016 2033 patent_owner Exhibit 2033 - Coherus IPR Petition Download
Apr 8, 2016 2023 patent_owner Exhibit 2023 - van Schouwenburg, et al. (2013) Download
Apr 8, 2016 2014 patent_owner Exhibit 2014 - Alemtuzumab/CAMPATH label Download
Apr 8, 2016 2027 patent_owner Exhibit 2027 - An (2010) Download
Apr 8, 2016 2041 patent_owner Exhibit 2041 - van de Putte, et al. (2003) Download
Jan 15, 2016 6 potential_po Related Matters Download
Jan 15, 2016 5 potential_po Power of Attorney Download
Jan 8, 2016 4 board Notice of Filing Date Accorded Download
Dec 29, 2015 3 petitioner Petition for Inter Partes Review of U.S. Patent No. 8,889,135 Download
Dec 29, 2015 1016 petitioner AbbVie's Clinical Review of Abbott's Biologic Licensing Application for adalimumab for the Treatment of RA, (Part 5) Download
Dec 29, 2015 1020 petitioner van de Putte 2004 Download
Dec 29, 2015 1029 petitioner Kempeni 2000 Download
Dec 29, 2015 1021 petitioner Keystone 2004 Download
Dec 29, 2015 1017 petitioner FDA's Clinical Review of Abbott's Biologic Licensing Application for adalimumab for the Treatment of RA Download
Dec 29, 2015 1022 petitioner Clinical Development Programs for Drugs, Devices and Biological Products for the Treatment of Rheumatoid Arthritis (1999) Download
Dec 29, 2015 1028 petitioner Hanauer 1999 Download
Dec 29, 2015 1019 petitioner FDA Clinical Pharmacology and Biopharmaceutics Review Download
Dec 29, 2015 1025 petitioner U.S. Patent No. 6,090,382 to Salfeld at al. Download
Dec 29, 2015 1026 petitioner U.S. Provisional Patent Application No. 60/296,961 Download
Dec 29, 2015 1018 petitioner European Medicines Agency, Scientific Discussion (2004) Download
Dec 29, 2015 1023 petitioner Applicant's Remarks/Arguments in Response to Oppositions to European Patent 1406656B (Dec. 22, 2014) Download
Dec 29, 2015 1011 petitioner Kempeni 1999 Download
Dec 29, 2015 1014 petitioner Weisman (2000) Download
Dec 29, 2015 1012 petitioner Rau 2000 (English Translation) Download
Dec 29, 2015 1015 petitioner REMICADE Summary Basis of Approval (1998) Download
Dec 29, 2015 1030 petitioner Rau 1999 Download
Dec 29, 2015 2 petitioner Power of Attorney Download
Dec 29, 2015 1013 petitioner Rau 2000 (German Original) Download
Dec 29, 2015 1027 petitioner Shargel 1999 Download
Dec 29, 2015 1024 petitioner HUMIRA Product Label Download
Dec 29, 2015 1001 petitioner U.S. Patent No. 8,889,135 Download
Dec 29, 2015 1004 petitioner Declaration of Dr. William J. Jusko, Ph.D. Download
Dec 29, 2015 1002 petitioner Prosecution History of the '135 patent (excerpts) - PART 2 of 4 Download
Dec 29, 2015 1 petitioner Power of Attorney Download
Dec 29, 2015 1008 petitioner van de Putte 1999 Download
Dec 29, 2015 1009 petitioner van de Putte 2000 (59 (Supp.) Ann. of the Rheum. Dis.) Download
Dec 29, 2015 1003 petitioner Declaration of Michael H. Weisman, M.D. Download
Dec 29, 2015 1006 petitioner Rau 1998 Download
Dec 29, 2015 1010 petitioner van de Putte 2000 (43 (Supp.) Arthritis and Rheum.) Download
Dec 29, 2015 1005 petitioner van de Putte 1998 Download
Dec 29, 2015 1007 petitioner Schattenkirchner 1998 Download
Dec 29, 2015 1002 petitioner Prosecution History of the '135 patent (excerpts) - PART 2 of 4 Download
Dec 29, 2015 1002 petitioner Prosecution History of the '135 patent (excerpts) - PART 2 of 4 Download
Dec 29, 2015 1002 petitioner Prosecution History of the '135 patent (excerpts) - PART 2 of 4 Download
Dec 29, 2015 1002 petitioner Prosecution History of the '135 patent (excerpts) - PART 3 of 4 Download
Dec 29, 2015 1002 petitioner Prosecution History of the '135 patent (excerpts) - PART 4 of 4 Download
Dec 29, 2015 1002 petitioner Prosecution History of the '135 patent (excerpts) - PART 1 of 4 Download
Menu